focus -WSS

focus

author：leisure time 2025-08-19 18:02:41 - browse：2613

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： CDC wastewater surveillance dashboard to track bird flu hotspots

leisure time

WSS

Elevance, private equity launch primary care company

Use wet bulb globe temperature, not heat index, to protect workers

Sanofi strikes deal with Novavax, boosting the vaccine maker

Brain worms: The science behind RFK Jr.'s parasitic infection

What the US credit downgrade means for the economy, your finances

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Wikipedia

focus

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Elevance, private equity launch primary care company

Virginia high school admissions case could be legal follow

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Novavax promises a turnaround & Lilly roils the obesity market

Micronoma's microbiome cancer diagnostic approach under fire

Medical records are filled with copy

What the airline industry can learn from medicine

United colonoscopy coverage change 'may cost lives,' doctors say

Apple Watch's A

knowledge

Physician groups backed by private equity giant lobby on mergers

The high personal cost of affirmative action for Black doctors

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Readout LOUD podcast: What to know about H5N1 bird flu

‘Oppenheimer’ and the risks of AI in health care

Steward Health Care files for bankruptcy

explore

explore

leisure time

hotspot